During an April 8, 2024 inspection, Luxe Seafood, Inc. in Los Angeles was cited once by the Food and Drug Administration (FDA) for issues related to foodborne biological hazards, according to data posted on the FDA’s website.
The FDA website shows that the company was cited for the following problem: ‘You do not have or have not implemented an affirmative step for ensuring that fish you import are processed in compliance with the Seafood HACCP regulation.’
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
